- Report
- March 2025
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- August 2024
- 163 Pages
Global
From €2721EUR$2,990USD£2,333GBP
- Report
- September 2024
- 100 Pages
Asia Pacific
From €5415EUR$5,950USD£4,642GBP
- Report
- January 2022
- 175 Pages
Global
From €4368EUR$4,799USD£3,744GBP
- Report
- July 2022
- 317 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- September 2023
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
Biopharma Excipients are substances used as inactive ingredients in biopharmaceuticals. They are added to the drug formulation to improve the stability, safety, and efficacy of the drug. Excipients can also be used to improve the taste, texture, and appearance of the drug. They are also used to increase the solubility of the drug, allowing it to be absorbed more quickly and efficiently. Excipients are also used to control the release of the drug, allowing it to be released over a longer period of time.
The biopharma excipients market is a rapidly growing sector, driven by the increasing demand for biopharmaceuticals. The market is expected to grow due to the increasing prevalence of chronic diseases, the rising demand for personalized medicines, and the growing demand for cost-effective drugs.
Some of the major companies in the biopharma excipients market include BASF, Evonik Industries, Ashland, Croda International, and Lubrizol Corporation. Show Less Read more